MWNA
OLMA icon

Marshall Wace North America’s Olema Pharmaceuticals OLMA Stock Holding History

Marshall Wace North America’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$701K Buy
+25,464
New +$687K ﹤0.01% 1036
2021
Q1 		– Sell
-23,793
Closed -$1.14M – 1697
2020
Q4 		$1.14M Buy
+23,793
New +$1.12M 0.01% 906

Other funds holding OLMA

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Marshall Wace North America's OLMA Position: Q3 2021 in Review

Marshall Wace North America opened a new position in Olema Pharmaceuticals (OLMA) in Q3 2021: 25,464 shares worth $701K. The stake represents ﹤0.01% of the portfolio and ranks #1036 among its holdings. This is a return to the name: Marshall Wace North America previously reported a position in OLMA as recently as Q4 2020.

Marshall Wace North America first reported a position in OLMA in Q4 2020 and has held it in 2 quarters since. The position peaked at $1.14M in Q4 2020. 76 funds tracked by Wall St. Rank hold OLMA as of Q3 2021.

  • Marshall Wace North America held 25,464 shares of Olema Pharmaceuticals worth $701K as of Q3 2021.
  • Olema Pharmaceuticals was a new Marshall Wace North America position in Q3 2021.
  • Olema Pharmaceuticals made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #1036 holding.
  • Marshall Wace North America first reported a position in Olema Pharmaceuticals in Q4 2020 and has held it in 2 quarters since.
  • Marshall Wace North America's Olema Pharmaceuticals position peaked at $1.14M in Q4 2020.
  • 76 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.